p53-based therapeutics for head and neck squamous cell carcinoma - Wikidata - awgldk - TriplyDB

p53-based therapeutics for head and neck squamous cell carcinoma

p53-based therapeutics for head and neck squamous cell carcinoma

http://www.wikidata.org/entity/Q38102472

about

The Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck Cancer Nucleic acid targeting: towards personalized therapy for head and neck cancer.Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma Molecular Aspects of Head and Neck Cancer Therapy Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.Sequencing the head and neck cancer genome: implications for therapy Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications.Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma.Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises.TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients.Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial.The Expression Levels of XLF and Mutant P53 Are Inversely Correlated in Head and Neck Cancer Cells.

P2860

Q26778433-528806FE-A914-4DD4-BEA2-8504D80858E7 Q26850237-88AC4180-421C-460E-9051-FAC3518F2BDC Q28074691-0775C66C-5FB7-483C-93CE-52B01776E63D Q28082815-6DCB1351-9C7A-45A3-A38A-EE5BBA98D760 Q34678948-CE724D02-9047-4474-82E7-19A460116B76 Q35087559-58AD3A17-8ACF-44A4-BD86-318D2F9D5F24 Q35101047-79D98342-4C2C-4FA0-838D-2037A0600CD1 Q38226307-C9948BA4-402D-4B14-8190-B9B095E42D5B Q38263740-32274E3F-D3FD-47DA-A3F1-A719A8D1F4DC Q38692795-ADED92A1-4B3E-4C77-AB92-35A7BD846D22 Q38831709-1B542822-3E11-4DAF-8232-C74D23CEFDDF Q39877713-867ACDBD-96A8-4C1C-B8A9-20A8517F08B8 Q42263612-3B490BA3-6CF7-4920-BCEB-52E8D27DDF8A Q42267124-EB9F2156-39C5-4B5C-92BF-4B953E464777 Q42397956-E73DB3F9-F628-4376-86E8-45194E0A915F

P2860

p53-based therapeutics for head and neck squamous cell carcinoma

http://www.wikidata.org/entity/Q38102472

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

p53-based therapeutics for head and neck squamous cell carcinoma

@en

type

label

p53-based therapeutics for head and neck squamous cell carcinoma

@en

prefLabel

p53-based therapeutics for head and neck squamous cell carcinoma

@en

P1433

Q38102472-E85C8203-AE41-4C71-89B6-F87A92E7D8A3

P1476

Q38102472-844C0AA6-68E2-4EA3-A08D-6B5DC350F948

P2093

Q38102472-109EBDAC-6254-4626-B303-AECDF8519C99

Q38102472-28B0B87F-4887-448A-BC1E-1372BB9B9E65

Q38102472-2BF0B6C0-485D-47F4-B951-8899B5F6D82B

Q38102472-B1EF4B43-3EC5-4C01-ABF9-D3CC39FD4793

P2860

Q38102472-0CE41807-50BD-4075-9F52-3FA29F73EA58

Q38102472-0E806CDB-2962-4A6C-8820-15E6939104C0

Q38102472-16FB4466-5B64-45CB-AC27-C6CF6F241E18

Q38102472-1F9A56D4-D9B9-47DB-A73A-D801FA81E284

Q38102472-2EA589DB-B13B-4C03-BAFD-D945DF1D403F

Q38102472-33CCED5A-0978-461B-A945-88CA19AEB8CF

Q38102472-38BEE213-C3B4-467E-BC82-79FDFFCE3B05

Q38102472-430C8A4F-7EE0-49DB-80E7-A144D79AB58A

Q38102472-4346CC67-1894-4280-8F63-E936F8B728B3

Q38102472-4521A95C-4257-4844-A3E8-B21B95322319

P304

Q38102472-61231C5B-9F0A-4A70-BA66-FC100FF36952

P31

Q38102472-B4921A37-B599-4C24-99F8-4620CAA86B32

P356

Q38102472-FFF558DA-A99D-430A-B0AF-B7779F338891

P407

Q38102472-709B7871-B3A2-47B6-98B8-48856EC83685

P433

Q38102472-E9F3ABF2-6D4E-4942-A549-1CDD5B826710

P478

Q38102472-409D6A29-5D76-491D-9E8E-6B09B73C4A95

P577

Q38102472-7CC61C51-8595-4F30-BBD0-80B099BD53AA

P698

Q38102472-66E796C7-D2E8-48E5-9314-5E4ABEC675A0

P932

Q38102472-23D1CE3E-883E-43A1-B237-ED1203D08AC7

P356

J.ORALONCOLOGY.2013.03.447

P1433

P1476

p53-based therapeutics for head and neck squamous cell carcinoma

@en

P2093

Matthew Old

http://www.w3.org/2001/XMLSchema#string

Patrick Tassone

http://www.w3.org/2001/XMLSchema#string

Quintin Pan

http://www.w3.org/2001/XMLSchema#string

Theodoros N Teknos

http://www.w3.org/2001/XMLSchema#string

P2860

Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

Cancer statistics, 2012

Mutations in the p53 gene occur in diverse human tumour types

T antigen is bound to a host protein in SV40-transformed cells

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

Transfection of mutant p53 gene depresses X-ray- or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neck.

P304

733-737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ORALONCOLOGY.2013.03.447

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23623836

http://www.w3.org/2001/XMLSchema#string

P932

3710521

http://www.w3.org/2001/XMLSchema#string